Cargando…
Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease
INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578582/ https://www.ncbi.nlm.nih.gov/pubmed/29201746 http://dx.doi.org/10.5005/jp-journals-10018-1186 |
_version_ | 1783260561641832448 |
---|---|
author | Tekatas, Demet D Bahcecioglu, Ibrahim H Ispiroglu, Murat Sahin, Abdurrahman Ilhan, Necip Yalniz, Mehmet Demirel, Ulvi |
author_facet | Tekatas, Demet D Bahcecioglu, Ibrahim H Ispiroglu, Murat Sahin, Abdurrahman Ilhan, Necip Yalniz, Mehmet Demirel, Ulvi |
author_sort | Tekatas, Demet D |
collection | PubMed |
description | INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body mass index, waist circumference, lipid parameters, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model assessment-IR (HOMA-IR), ACE, and ACE gene polymorphism were evaluated in the NAFLD group and control group. The study group was evaluated by dividing the group into four subgroups by ACE gene polymorphism (D/D homozygous, I/I homozygous, D/I heterozygous, I/D heterozygous). Liver biopsies were evaluated according to Brunt Classification. RESULTS: A total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study. The ACE level was found to be 11.69 ± 1.99 in the NAFLD group and 11.52 ± 1.72 in the control group (p = 0.70). There was a negative correlation between ACE levels and HOMA-IR levels (p = 0.008, r= −0.512). Biochemical parameters were not different among ACE gene polimorphism subgroups, except FBG (between D/D, I/D and D/I, I/D; p = 0.02). When the ACE levels were compared in terms of grade and stage, no significant difference was found (for stage and grade p = 0.68). The ACE gene polymorphism subgroups did not differ by histopathologic findings; grade and stage (for grade p = 0.42, for stage p = 0.92). CONCLUSION: In this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD. HOW TO CITE THIS ARTICLE: Tekatas DD, Bahcecioglu IH, Ispiroglu M, Sahin A, Ilhan N, Yalniz M, Demirel U. Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2016;6(2):137-142. |
format | Online Article Text |
id | pubmed-5578582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-55785822017-11-30 Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease Tekatas, Demet D Bahcecioglu, Ibrahim H Ispiroglu, Murat Sahin, Abdurrahman Ilhan, Necip Yalniz, Mehmet Demirel, Ulvi Euroasian J Hepatogastroenterol Research Article INTRODUCTION: In this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. MATERIALS AND METHODS: Liver function tests, body mass index, waist circumference, lipid parameters, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model assessment-IR (HOMA-IR), ACE, and ACE gene polymorphism were evaluated in the NAFLD group and control group. The study group was evaluated by dividing the group into four subgroups by ACE gene polymorphism (D/D homozygous, I/I homozygous, D/I heterozygous, I/D heterozygous). Liver biopsies were evaluated according to Brunt Classification. RESULTS: A total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study. The ACE level was found to be 11.69 ± 1.99 in the NAFLD group and 11.52 ± 1.72 in the control group (p = 0.70). There was a negative correlation between ACE levels and HOMA-IR levels (p = 0.008, r= −0.512). Biochemical parameters were not different among ACE gene polimorphism subgroups, except FBG (between D/D, I/D and D/I, I/D; p = 0.02). When the ACE levels were compared in terms of grade and stage, no significant difference was found (for stage and grade p = 0.68). The ACE gene polymorphism subgroups did not differ by histopathologic findings; grade and stage (for grade p = 0.42, for stage p = 0.92). CONCLUSION: In this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD. HOW TO CITE THIS ARTICLE: Tekatas DD, Bahcecioglu IH, Ispiroglu M, Sahin A, Ilhan N, Yalniz M, Demirel U. Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2016;6(2):137-142. Jaypee Brothers Medical Publishers 2016 2016-12-01 /pmc/articles/PMC5578582/ /pubmed/29201746 http://dx.doi.org/10.5005/jp-journals-10018-1186 Text en Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Research Article Tekatas, Demet D Bahcecioglu, Ibrahim H Ispiroglu, Murat Sahin, Abdurrahman Ilhan, Necip Yalniz, Mehmet Demirel, Ulvi Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title | Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title_full | Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title_fullStr | Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title_full_unstemmed | Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title_short | Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
title_sort | role of renin–angiotensin-converting enzyme level and ace gene polymorphism in patients with nonalcoholic fatty liver disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578582/ https://www.ncbi.nlm.nih.gov/pubmed/29201746 http://dx.doi.org/10.5005/jp-journals-10018-1186 |
work_keys_str_mv | AT tekatasdemetd roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT bahceciogluibrahimh roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT ispiroglumurat roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT sahinabdurrahman roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT ilhannecip roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT yalnizmehmet roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease AT demirelulvi roleofreninangiotensinconvertingenzymelevelandacegenepolymorphisminpatientswithnonalcoholicfattyliverdisease |